Women's Health 2021: Beyond the Annual Visit - Southeast

During any visit, we must use a far broader lens on issues facing the female patient. That’s why there’s Women’s Health 2021: Beyond the Annual Visit.

Live Broadcast
6.25 available credits
Information
October 29, 2021
08:00 AM - 03:00 PM EDT
Online
Southeast
ReachMD Healthcare Image
Choose a format
Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2021: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts who discuss the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson as this year's Program Director and Moderator!

    Join the conversation #WH21

    Please see when the Live Broadcast will begin in your timezone:
    • 8 AM ET
    • 7 AM CT
    • 6 AM MT
    • 5 AM PT
  • Program Schedule*

    8:00 am–8:15 am

    Welcome, Introductions, Program Announcements
    Anita L. Nelson, MD
    Program Chair

    Session 1

    8:15 am–8:35 am

    Expanding Contraceptive Choices for Women: The Vaginal pH Modulator
    David L. Eisenberg, MD, MPH, FACOG

    8:35 am–9:35 am

    Optimizing Medical Management of Uterine Fibroids
    Linda D. Bradley, MD
    Sukhbir Sony Singh, MD
    Sateria Venable

    9:35 am–10:20 am

    A Closer Look at Women, Atherosclerosis and Lipids:  What is Different?
    Gregory Pokrywka, MD, FACP, FNLA, FASPC, NCMP
    Karol Watson, MD, PhD

    10:20 am–10:35 am

    Question & Answer Session

    10:35 am–10:45 am

    Break

    Session 2

    10:45 am–11:15 am

    Shining a New Light on the Contraceptive Patch
    Brooke Faught, DNP, WHNP-BC, NCMP, FAANP, IF

    11:15 am–12:00 pm

    Addressing the Unique Needs of Women with Migraine
    Peter Goadsby, MD, PhD, DSc
    Kathleen Mullin, MD

    12:00 pm–12:15 pm

    Question & Answer Session

    12:15 am–12:40 pm

    Break

    Session 3

    12:40 pm–1:10 pm

    Featured Lunch Presentation
    Trending: What Else is New in Women’s Care?
    Anita L. Nelson, MD

    1:10 pm–1:40 pm

    Managing Vulvovaginal Candidiasis—Riding the Wave of Therapeutic Change
    Paul Nyirjesy, MD

    1:40 pm-1:55 pm

    Question & Answer Session

    Session 4

    1:55 pm–2:10 pm

    Act Fast: Understanding Flu Prevention and Treatment in At-Risk Populations
    Cassandra B. Donnelly, DO
    Charles P. Vega, MD

    2:10 pm–2:40 pm

    Cardiovascular Disease Prevention in Patients with Polycystic Ovary Syndrome 
    Eliot Brinton, MD, FAHA, FNLA

    2:40 pm-2:55 pm 

    Question & Answer Session


    2:55 pm–3:00 pm

    Closing Remarks

    *Subject to change

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology,
    David Geffen School of Medicine at UCLA
    Clinical Professor Obstetrics & Gynecology,
    University Southern California, Los Angeles, CA
    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD                   
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research:  Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Faculty:

    Linda D. Bradley, MD
    Professor, Obstetrics and Gynecology and Reproductive Biology
    Cleveland Clinic
    Cleveland, OH
    No relevant relationship reported

    Eliot A. Brinton, MD, FAHA, FNLA, FACE
    President
    Utah Lipid Center
    Salt Lake City, UT
    Consulting Fees:
    Amarin, Esperion, Kowa
    Commercial Interest Speakers Bureau:
    Amarin, Amgen, Boehringer, Kowa, Merck, Nova, Regeneron, Sanofi

    Cassandra B. Donnelly, DO
    Regional Medical Director
    Piedmont Urgent Care
    Atlanta, GA
    No relevant relationship reported

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University School of Medicine in St. Louis
    St. Louis, MO
    Consulting Fees: Evofem, Femosys, Medicines360, Sebela Pharmaceuticals Inc./ACI Clinical
    Commercial Interest Speakers Bureau: Evofem, Merck
    Contracted Research: Medinines360, Merck
    Ownership Interest: Femosys

    Brooke M. Faught, DNP, WHNP, NCMP, FAANP, IF
    Director of the Women’s Institute for Sexual Health (WISH)
    Nashville, TN
    Consulting Fees: Mayne Pharm, SCYNEXIS, Trophikos
    Speakers Bureau: Agile Therapeutics, JDS Therapeutics, Palatin, TherapeuticsMD
    Contracted Research: Dare Bioscience, IPSEN Innovation

    Peter Goadsby, MD, PhD, DSc
    Professor of Neurology
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Aeon Biopharma, Amgen, Allergan, Biohaven Pharmaceuticals Inc., Eli Lilly and Company, Epalex, GlaxoSmithKline, Impel Neuropharma, Lundbeck, Novartis, Pfizer
    Research Grants: Amgen, Celgene, Eli Lilly and Company

    Kathleen Mullin, MD
    Medical Director, Clinical Research
    New England Institute for Neurology and Headache
    Stamford, CT
    Consulting Fees: Biohaven Pharmaceuticals, Lilly
    Speaker Bureau: Biohaven Pharmaceuticals, Lilly, Teva

    Paul Nyirjesy, MD
    Professor of Obstetrics & Gynecology
    Co-director, Jefferson Vulvovaginal Health Center
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, PA
    Consulting Fees: Hologic, Inc., Mycovia Pharmaceuticals, SCYNEXIS, Inc.

    Gregory S. Pokrywka MD, FACP, FNLA, FASPC, NCMP
    Director: Baltimore Lipid Center
    Assistant Professor
    Johns Hopkins University School of Medicine
    Baltimore, MD
    Commercial Interest Speakers Bureau: Amarin, Amgen, Esperion 

    Sukhbir Sony Singh, MD
    Professor, Department of Obstetrics & Gynecology
    The Ottawa Hospital/University of Ottawa
    Associate Scientist and the Dr. E. Jolly Research Chair in Gynecologic Surgery
    The Ottawa Hospital Research Institute
    Ottawa, ON Canada
    Consulting Fees & Speaker Bureau: AbbVie

    Charles P. Vega, MD
    Clinical Professor, Family Medicine
    School of Medicine
    University of California, Irvine
    Orange, CA
    No relevant relationship reported

    Sateria Venable
    Founder & CEO of The Fibroid Foundation
    Bethesda, MD
    Consulting Fees: AbbVie

    Karol Watson, MD, PhD
    Professor of Medicine/Cardiology
    Co-director, UCLA Program in Preventive Cardiology
    Director, UCLA Barbra Streisand Women's Heart Health Program
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Amarin, Amgen, Boehringer-Ingelheim, Lilly, Esperion, Novo Nordisk

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Nick Lomardi has no relevant relationship to report.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family practice, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative (GLC) designates this activity for 6.25 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by independent educational grants from Agile Therapeutics, Amarin Pharma, Inc., Biohaven Pharmaceuticals, Evofem Biosciences, and SCYNEXIS.

  • How To Claim Your Credits

    How do I get my Credits/Certificate?

    You will receive an e-mail with a link to the post-test after today’s activity.  Your certificate will be made available to you upon completion of the post-test.

    (If you don’t receive the post-test check your spam/junk mail)

    OR

    Complete the post-test online and download your certificate instantly. Here's how:

    1.    Log in to our website, www.OmniaEducation.com
    2.    Once logged in, click on the Profile button in the top right, corner
    3.    Hover over My Live Events
    4.    A dropdown menu will appear
    5.    Click on Past Events
    6.    Click on Take Post-Test
    7.    Once post-test has been completed, you will receive an email to download the Certificate or go to your Profile/Credits, click Download.

Facebook Comments

Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2021: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts who discuss the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson as this year's Program Director and Moderator!

    Join the conversation #WH21

    Please see when the Live Broadcast will begin in your timezone:
    • 8 AM ET
    • 7 AM CT
    • 6 AM MT
    • 5 AM PT
  • Program Schedule*

    8:00 am–8:15 am

    Welcome, Introductions, Program Announcements
    Anita L. Nelson, MD
    Program Chair

    Session 1

    8:15 am–8:35 am

    Expanding Contraceptive Choices for Women: The Vaginal pH Modulator
    David L. Eisenberg, MD, MPH, FACOG

    8:35 am–9:35 am

    Optimizing Medical Management of Uterine Fibroids
    Linda D. Bradley, MD
    Sukhbir Sony Singh, MD
    Sateria Venable

    9:35 am–10:20 am

    A Closer Look at Women, Atherosclerosis and Lipids:  What is Different?
    Gregory Pokrywka, MD, FACP, FNLA, FASPC, NCMP
    Karol Watson, MD, PhD

    10:20 am–10:35 am

    Question & Answer Session

    10:35 am–10:45 am

    Break

    Session 2

    10:45 am–11:15 am

    Shining a New Light on the Contraceptive Patch
    Brooke Faught, DNP, WHNP-BC, NCMP, FAANP, IF

    11:15 am–12:00 pm

    Addressing the Unique Needs of Women with Migraine
    Peter Goadsby, MD, PhD, DSc
    Kathleen Mullin, MD

    12:00 pm–12:15 pm

    Question & Answer Session

    12:15 am–12:40 pm

    Break

    Session 3

    12:40 pm–1:10 pm

    Featured Lunch Presentation
    Trending: What Else is New in Women’s Care?
    Anita L. Nelson, MD

    1:10 pm–1:40 pm

    Managing Vulvovaginal Candidiasis—Riding the Wave of Therapeutic Change
    Paul Nyirjesy, MD

    1:40 pm-1:55 pm

    Question & Answer Session

    Session 4

    1:55 pm–2:10 pm

    Act Fast: Understanding Flu Prevention and Treatment in At-Risk Populations
    Cassandra B. Donnelly, DO
    Charles P. Vega, MD

    2:10 pm–2:40 pm

    Cardiovascular Disease Prevention in Patients with Polycystic Ovary Syndrome 
    Eliot Brinton, MD, FAHA, FNLA

    2:40 pm-2:55 pm 

    Question & Answer Session


    2:55 pm–3:00 pm

    Closing Remarks

    *Subject to change

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology,
    David Geffen School of Medicine at UCLA
    Clinical Professor Obstetrics & Gynecology,
    University Southern California, Los Angeles, CA
    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD                   
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research:  Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Faculty:

    Linda D. Bradley, MD
    Professor, Obstetrics and Gynecology and Reproductive Biology
    Cleveland Clinic
    Cleveland, OH
    No relevant relationship reported

    Eliot A. Brinton, MD, FAHA, FNLA, FACE
    President
    Utah Lipid Center
    Salt Lake City, UT
    Consulting Fees:
    Amarin, Esperion, Kowa
    Commercial Interest Speakers Bureau:
    Amarin, Amgen, Boehringer, Kowa, Merck, Nova, Regeneron, Sanofi

    Cassandra B. Donnelly, DO
    Regional Medical Director
    Piedmont Urgent Care
    Atlanta, GA
    No relevant relationship reported

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University School of Medicine in St. Louis
    St. Louis, MO
    Consulting Fees: Evofem, Femosys, Medicines360, Sebela Pharmaceuticals Inc./ACI Clinical
    Commercial Interest Speakers Bureau: Evofem, Merck
    Contracted Research: Medinines360, Merck
    Ownership Interest: Femosys

    Brooke M. Faught, DNP, WHNP, NCMP, FAANP, IF
    Director of the Women’s Institute for Sexual Health (WISH)
    Nashville, TN
    Consulting Fees: Mayne Pharm, SCYNEXIS, Trophikos
    Speakers Bureau: Agile Therapeutics, JDS Therapeutics, Palatin, TherapeuticsMD
    Contracted Research: Dare Bioscience, IPSEN Innovation

    Peter Goadsby, MD, PhD, DSc
    Professor of Neurology
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Aeon Biopharma, Amgen, Allergan, Biohaven Pharmaceuticals Inc., Eli Lilly and Company, Epalex, GlaxoSmithKline, Impel Neuropharma, Lundbeck, Novartis, Pfizer
    Research Grants: Amgen, Celgene, Eli Lilly and Company

    Kathleen Mullin, MD
    Medical Director, Clinical Research
    New England Institute for Neurology and Headache
    Stamford, CT
    Consulting Fees: Biohaven Pharmaceuticals, Lilly
    Speaker Bureau: Biohaven Pharmaceuticals, Lilly, Teva

    Paul Nyirjesy, MD
    Professor of Obstetrics & Gynecology
    Co-director, Jefferson Vulvovaginal Health Center
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, PA
    Consulting Fees: Hologic, Inc., Mycovia Pharmaceuticals, SCYNEXIS, Inc.

    Gregory S. Pokrywka MD, FACP, FNLA, FASPC, NCMP
    Director: Baltimore Lipid Center
    Assistant Professor
    Johns Hopkins University School of Medicine
    Baltimore, MD
    Commercial Interest Speakers Bureau: Amarin, Amgen, Esperion 

    Sukhbir Sony Singh, MD
    Professor, Department of Obstetrics & Gynecology
    The Ottawa Hospital/University of Ottawa
    Associate Scientist and the Dr. E. Jolly Research Chair in Gynecologic Surgery
    The Ottawa Hospital Research Institute
    Ottawa, ON Canada
    Consulting Fees & Speaker Bureau: AbbVie

    Charles P. Vega, MD
    Clinical Professor, Family Medicine
    School of Medicine
    University of California, Irvine
    Orange, CA
    No relevant relationship reported

    Sateria Venable
    Founder & CEO of The Fibroid Foundation
    Bethesda, MD
    Consulting Fees: AbbVie

    Karol Watson, MD, PhD
    Professor of Medicine/Cardiology
    Co-director, UCLA Program in Preventive Cardiology
    Director, UCLA Barbra Streisand Women's Heart Health Program
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Amarin, Amgen, Boehringer-Ingelheim, Lilly, Esperion, Novo Nordisk

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Nick Lomardi has no relevant relationship to report.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family practice, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative (GLC) designates this activity for 6.25 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by independent educational grants from Agile Therapeutics, Amarin Pharma, Inc., Biohaven Pharmaceuticals, Evofem Biosciences, and SCYNEXIS.

  • How To Claim Your Credits

    How do I get my Credits/Certificate?

    You will receive an e-mail with a link to the post-test after today’s activity.  Your certificate will be made available to you upon completion of the post-test.

    (If you don’t receive the post-test check your spam/junk mail)

    OR

    Complete the post-test online and download your certificate instantly. Here's how:

    1.    Log in to our website, www.OmniaEducation.com
    2.    Once logged in, click on the Profile button in the top right, corner
    3.    Hover over My Live Events
    4.    A dropdown menu will appear
    5.    Click on Past Events
    6.    Click on Take Post-Test
    7.    Once post-test has been completed, you will receive an email to download the Certificate or go to your Profile/Credits, click Download.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free